Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview

被引：0
|
作者：
Lieven Pouillon
Séverine Vermeire
Peter Bossuyt
机构：
[1] Imelda GI Clinical Research Centre,Department of Gastroenterology and Hepatology
[2] Imeldaziekenhuis Bonheiden,undefined
[3] University Hospitals Leuven,undefined
[4] KU Leuven,undefined
来源：
BMC Medicine | / 17卷
关键词：
Crohn’s disease; Inflammatory bowel disease; Therapeutic drug monitoring; Vedolizumab; Ulcerative colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
    Pouillon, Lieven
    Vermeire, Severine
    Bossuyt, Peter
    [J]. BMC MEDICINE, 2019, 17 (1)
  • [2] Inflammatory bowel disease therapy: current state-of-the-art
    Blonski, Wojciech
    Buchner, Anna M.
    Lichtenstein, Gary R.
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (04) : 346 - 357
  • [3] VEDOLIZUMAB TROUGH LEVELS AND CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASE
    Guidi, L.
    Pugliese, D.
    Tonucci, T. Panici
    Tolusso, B.
    Felice, C.
    Papa, A.
    Ennas, S.
    Di Mario, C.
    Gasbarrini, A.
    Rapaccini, G. L.
    Armuzzi, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E99 - E100
  • [4] CLINICAL EXPERIENCE WITH VEDOLIZUMAB TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang Hyoung
    Aniwan, Satimai
    Raffals, Laura H.
    Tremaine, William J.
    Loftus, Edward V.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S821 - S822
  • [5] State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008
    Lynne V McFarland
    [J]. World Journal of Gastroenterology, 2008, (17) : 2625 - 2629
  • [6] State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008
    McFarland, Lynne V.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (17) : 2625 - 2629
  • [7] Vedolizumab Trough Levels in Inflammatory Bowel Disease: Initial Clinical Experience
    Badr, Al-Bawardy
    Guilherme, Piovezani Ramos
    Loftus, Edward, Jr.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S26 - S26
  • [8] Clinical utility of vedolizumab trough levels in the management of inflammatory bowel disease
    Maillard, Michel H.
    Jelk, Daniele
    Perreau, Matthieu
    Rossel, Jean-Benoit
    Pittet, Valerie
    Michetti, Pierre
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 6S - 6S
  • [9] Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease
    Guidi, L.
    Pugliese, D.
    Tonucci, T. Panici
    Tolusso, B.
    Felice, C.
    Di Mario, C.
    Papa, A.
    Gremese, E.
    Gasbarrini, A.
    Rapaccini, G. L.
    Armuzzi, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S398 - S398
  • [10] Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases
    Dreesen, Erwin
    Verstockt, Bram
    Bian, Sumin
    de Bruyn, Magali
    Compernolle, Griet
    Tops, Sophie
    Noman, Maja
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (12) : 1937 - +
12345